Epidemiology of Non-Alcoholic Fatty Liver Disease
The DOI matches its Crossref record; 76 of the 77 references it cites were found in a registry or an index.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is rapidly becoming the most common liver disease worldwide. The prevalence of NAFLD in the general population of Western countries is 20–30%. About 2–3% of the general population is estimated to have non-alcoholic steatohepatitis (NASH), which may progress to liver cirrhosis and hepatocarcinoma. As a rule, the prevalence of NAFLD is higher in males and increases with increasing age, and it is influenced by the diagnostic method and the characteristics of the population, especially lifestyle habits. Population-based studies provide better estimates of the prevalence of NAFLD as compared to autoptic and clinical studies, but few such studies have been performed to date. The diagnosis of NAFLD in population studies is usually obtained by ultrasonography, which is known to underestimate the prevalence of fatty liver. The Dallas Heart Study and the Dionysos Study reported that 30% of the adults in the USA and 25% in Italy have NAFLD. In these studies, 79% and 55% of patients with NAFLD had normal aminotransferase levels, showing that liver enzymes are not surrogate markers of NAFLD in the general population. Noninvasive markers such as the fatty liver index obtained from the Dionysos Study may be useful to screen for NAFLD in the general population. The most important risk factors for NAFLD are male gender, age, obesity, insulin resistance and the cardiometabolic alterations that define the metabolic syndrome. The prevalence of NAFLD is 80–90% in obese adults, 30–50% in patients with diabetes and up to 90% in patients with hyperlipidemia. The prevalence of NAFLD among children is 3–10%, rising up to 40–70% among obese children. Moreover, pediatric NAFLD increased from about 3% a decade ago to 5% today, with a male-to-female ratio of 2:1. The incidence and natural history of NAFLD are still not well defined, but it is recognized that the majority of individuals with NAFLD do not develop NASH. The incidence of NAFLD is probably increasing in Western countries, strictly linked to lifestyle habits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The prevalence of NAFLD among normal-weight children is 3–10%, rising up to 40–70% among obese children”
From Lack of Exercise Is a Major Cause of Chronic Diseases (2012) · cites this paper as [33]
Citations
Cites
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352 · cited 1×
“In the literature, many competing definitions of the MS are available. The definition recently put forth by the International Federation for the Study of Diabetes (IDF) [”
BackgroundNonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664 · cited 1×
“It is important to note that this prevalence is partly dependent upon the method used to diagnose FL, the method used to assess alcohol intake and the cutoff point used to exclude ‘relevant’ alcohol intake, see table 2 , with respective references [ , , , , , , , , , , , , , , , , , , , , , ,”
MethodNonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345 · cited 1×
“] and 15p in Asian countries [ , , , , , , , , , ,”
Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., & Tiribelli, C. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-33 · Cited by 3,042 · cited 1×
“We suggest to expand the number of prospective cohort studies in the general population, even if they are more expensive and difficult to handle, because they give more reliable results about the burden of disease attributable to NAFLD. The most simple, noninvasive and practical method for diagnosing FL in population…”
BackgroundSelf-citationLudwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679 · cited 1×
“Population and clinical studies have increasingly shown that most cases of NAFLD are associated with the metabolic syndrome (MS), so that NAFLD is presently considered the hepatic manifestation of MS [”
BackgroundNonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,154 · cited 1×
“Definition and Classification of Non-Alcoholic Fatty Liver DiseaseNon-alcoholic fatty liver disease (NAFLD) is operationally defined as fatty liver (FL), i.e. an accumulation of lipids inside the hepatocytes exceeding 5p of the weight of the liver, without hepatitis B virus or hepatitis C virus infection and in the ab…”
BackgroundIndependent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610 · cited 1×
“A recent study showed that 27p of US adults have raised levels of liver enzymes and that 79p of these values cannot be explained by the most common causes of liver disease [ , , , , , , , ,”
BackgroundAssociation of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli-Labate, A. M., Bianchi, G., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,568 · cited 1×
“While steatosis is usually associated with a benign prognosis, steatohepatitis and fibrosis may progress to cirrhosis and possibly hepatocarcinoma.During the last decade, the number of studies on NAFLD has grown exponentially, and new concepts have been acquired by the scientific community. We now know that NAFLD is o…”
Background
Research works printed but not linked: 7
- 10.1097%2f00005176-200001000-00017 · doi:10.1097/00005176-200001000-00017 · Paper page
- 10.1016%2fs1590-8658%2802%2980194-3 · DOI
- 10.1111%2fj.1572-0241.2001.04052.x · doi:10.1111/j.1572-0241.2001.04052.x · Paper page
- 10.1016%2fs0168-8278%2801%2900094-0 · DOI · Paper page
- 10.1111%2fj.1572-0241.1999.01451.x · doi:10.1111/j.1572-0241.1999.01451.x · Paper page
- 10.3109%2f00365527709181339 · DOI · Paper page
- 10.1053%2fgast.2001.25540 · DOI · Paper page
Cited by
Items 601–700 of 1,000
Ahmed, M., & Ahmed, M. H. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133893 · Cited by 13
The Future Liver of the Asia Pacific: Fatter and Firmer from More Fructose and Fortune?
Mahady, S. E., & George, J. (2012) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2012.10.011 · Cited by 13
Is non‐alcoholic fatty liver disease a reflection of what we eat or simply how much we eat?
Sharp, K., Schultz, M., & Coppell, K. J. (2018) · JGH Open · doi:10.1002/jgh3.12040 · Cited by 16
3-D Ultrafast Shear Wave Absolute Vibro-Elastography Using a Matrix Array Transducer
Hashemi, H. S., Mohammed, S. K., Zeng, Q., Azar, R. Z., Rohling, R. N., & Salcudean, S. E. (2023) · IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control · doi:10.1109/tuffc.2023.3280450 · Cited by 13
“rising up to 40 to 70% among obese children [25].”
BackgroundYang, H. R., Yi, D. Y., & Choi, H. S. (2014) · Journal of Korean Medical Science · doi:10.3346/jkms.2014.29.12.1672 · Cited by 14
Ji, B., Li, R., Zhang, S., Gong, L., Wang, Z., Ren, W., & Li, Q. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.06.019 · Cited by 13
Yamamoto, H., Kanno, K., Ikuta, T., Arihiro, K., Sugiyama, A., Kishikawa, N., & Tazuma, S. (2016) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.333 · Cited by 13
Effect of nonalcoholic steatohepatitis on renal filtration and secretion of adefovir
Laho, T., Clarke, J., Dzierlenga, A. L., Li, H., Klein, D., Goedken, M. J., Mičuda, S., & Cherrington, N. J. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.07.001 · Cited by 13
Salidroside and Curcumin Formula Prevents Liver Injury in Nonalcoholic Fatty Liver Disease in Rats
Li, H., Ying, H., & He, Z.-Y. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0012.3135 · Cited by 14
Yin, K., Zhou, X. J., Wei, J., Wang, L., Dai, Z., & Tang, B. (2021) · Disease Markers · doi:10.1155/2021/9963534 · Cited by 14
“Nonalcoholic fatty liver disease (NAFLD) is a global health problem, and its incidence is rapidly increasing, especially in the United States, where its prevalence is 20–30% [1].”
BackgroundTabaeian, S. P., Mahmoudi, T., Sabzikarian, M., Rezamand, G., Dabiri, R., Nobakht, H., Asadi, A., Farahani, H., Mansour‐Ghanaei, F., & Zali, M. R. (2021) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-2703 · Cited by 13
“Previous studies have shown that NAFLD shares genetic associations with metabolic syndrome‐associated disorders, including T2D, obesity, cardiovascular diseases and dyslipidemia.”
BackgroundInfluentialExercise during weight loss improves hepatic mitophagy
Rosa‐Caldwell, M. E., Poole, K. E., Seija, A., Harris, M. P., Greene, N. P., & Wooten, J. S. (2022) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2022.04.003 · Cited by 14
Liu, Y., Lu, J., Xu, M., Xu, Y., Li, M., Wang, T., Zhang, J., Xu, B., Sun, J., Dai, M., et al. (2013) · Annals of Epidemiology · doi:10.1016/j.annepidem.2012.12.002 · Cited by 14
Impact of Fibroblast Growth Factors 19 and 21 in Bariatric Metabolism
Patton, A., Khan, F. H., & Kohli, R. (2017) · Digestive Diseases · doi:10.1159/000450910 · Cited by 15
Yen, Y., Chen, J., Wu, C., Lin, M., Chang, K., Tseng, P., Tsai, M., Lin, J.-T., & Hu, T. (2017) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2017.08.010 · Cited by 13
Non-alcoholic fatty liver disease: mind the gaps: pathophysiology and non-invasive diagnosis
Verhaegh, P. L. M. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210428pv · Cited by 13
Diagnostic of fatty liver using radiomics and deep learning models on non-contrast abdominal CT
Zhang, H., Liu, J., Su, D., Bai, Z., Wu, Y. X., Ma, Y., Miao, Q., Wang, M., & Yang, X. (2025) · PLoS ONE · doi:10.1371/journal.pone.0310938 · Cited by 12
Gastric Bypass and Influence on Improvement of NAFLD
Alli, V. V., & Rogers, A. M. (2017) · Current Gastroenterology Reports · doi:10.1007/s11894-017-0567-8 · Cited by 12
Nonalcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic
Ahmed, M., & Ahmed, M. H. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i17.4133 · Cited by 16
Obesity influences the development of bisphosphonate-induced osteonecrosis in Wistar rats
Lima, W. J. D. M., de Pontes, J. C. X., FIGUEIREDO, L. S. D., Araújo, R. D. S., Sousa, M. C. D. P., Aquino, J. D. S., de Castro, R. D., & Alves, A. F. (2023) · Journal of Applied Oral Science · doi:10.1590/1678-7757-2023-0133 · Cited by 12
Wu, G., Wang, K., Xue, Y., Song, G., Wang, Y., Sun, X., Zhong, L., Zhou, C., Shen, B., Chen, J., et al. (2015) · Gene · doi:10.1016/j.gene.2015.09.007 · Cited by 12
DeSantis, D., Ko, C.-W., Wang, L., Lee, P., & Croniger, C. M. (2015) · Mediators of Inflammation · doi:10.1155/2015/909827 · Cited by 12
Bharath, R., & Rajalakshmi, P. (2017) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2017.8037239 · Cited by 14
“It is estimated that 20-30% of the general population in western countries and up to 40% in developing countries like India are suffering with fatty liver [1].”
BackgroundAtwa, H., Gad, K., Hagrasy, H., Elkelany, A., Azzam, M., Bayoumi, N., Gobarah, A. A., & Shora, H. (2018) · Archives of Medical Science · doi:10.5114/aoms.2018.74226 · Cited by 12
“6% of children in the general population [1, 3].”
BackgroundResultInfluentialDerakhshandeh‐Rishehri, S., Heidari‐Beni, M., & Eftekhari, M. H. (2020) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2020.223 · Cited by 13
Ettorre, G. M. (2022) · Updates in surgery/Updates in surgery series · doi:10.1007/978-3-031-09371-5 · Cited by 12
Jahromi, M. K., Tehrani, A. N., Teymoori, F., Daftari, G., Ahmadirad, H., Saber, N., Salehi‐Sahlabadi, A., Farhadnejad, H., & Mirmiran, P. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01365-8 · Cited by 13
“6% in the USA [6], 25% in Asia [7], 25% in Europe [8], and a total of 15–30% in the general population [9].”
BackgroundInfluentialWang, Y., Tong, J., Chang, B., Wang, B., Zhang, D., & Wang, B. (2014) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2014.0116 · Cited by 14
“Generally, the prevalence of NAFLD in the general population is estimated to be 20–30% and * 15% in Western and Asian countries, respectively (Bellentani et al. , 2010).”
Chaves, G. V., de Souza, D. S., Pereira, S., Saboya, C. J., & Peres, W. A. F. (2012) · Revista da Associação Médica Brasileira · doi:10.1590/s0104-42302012000300007 · Cited by 12
Complement Component 3 Is Associated with Metabolic Comorbidities in Older HIV-Positive Adults
Bryant, A. K., Fazeli, P. L., Letendre, S. L., Ellis, R. J., Potter, M., Burdo, T. H., Singh, K. K., Jeste, D. V., Grant, I., & Moore, D. J. (2015) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2015.0179 · Cited by 12
“Higher C3 is also associated with nonalcoholic fatty liver disease, the primary liver manifestation of MetS, and may contribute to the impaired liver function and dyslipidemia observed in cardiometabolic disease.(16,17) The complement system has been hypothesized to play a role in the development of MetS and may be in…”
BackgroundHashimoto, M., Tashiro, H., Kobayashi, T., Kuroda, S., Hamaoka, M., & Ohdan, H. (2017) · International Journal of Surgery · doi:10.1016/j.ijsu.2017.01.110 · Cited by 12
Nonalcoholic Fatty Liver Disease
Palmer, M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0548-5_10 · Cited by 13
Billeter, A. T., Reiners, B., Seide, S. E., Probst, P., Kalkum, E., Rupp, C., & Müller-Stich, B. P. (2022) · Hepatobiliary Surgery and Nutrition · doi:10.21037/hbsn-21-5 · Cited by 12
“This chronic liver disease is associated with an increased risk for liver failure and hepatocellular carcinoma (HCC) and is expected to become the main indication for liver transplantation in the United States and worldwide in the next years (3).”
BackgroundChoi, S. W., Oh, H., Park, S. Y., Cho, W., El‐Aty, A. M. A., Hacımüftüoğlu, A., Jeong, J. H., & Jung, T. W. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.30982 · Cited by 11
“Over 70% of MAFLD patients have insulin resistance and type 2 diabetes and are at risk for cardiovascular disease (Bellentani et al., 2010; Schindhelm et al., 2007).”
BackgroundErman, H., Böyük, B., Arslan, Ş., Akın, S., & Keskin, Ö. (2024) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2024.0022 · Cited by 11
Kim, H., Jeon, H.-J., Kim, D., Kim, J.-Y., Shim, J.-J., & Lee, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189870 · Cited by 13
“The global prevalence of NAFLD is estimated to be approximately 32%, and it is more prevalent in men than in women (33% in men and 20% in women) [4,5].”
BackgroundZhang, Z., Zhu, T., Li, Y., Yu, B., Tao, H., Zhao, H., & Cui, B. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c07966 · Cited by 11
Hígado graso no alcohólico. Documento de posicionamiento de la Societat Catalana de Digestologia
Caballería, L., Saló, J., Berzigotti, A., Planas, R., Vila, M. C., Huertas, C., Torres, M., Torán‐Monserrat, P., & Caballería, J. (2014) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2014.03.005 · Cited by 12
Endoplasmic reticulum stress increases LECT2 expression via ATF4
Park, C. Y., Lee, S. K., Kim, J., Kim, D., Choe, H., Jeong, J., Choi, K., Park, H. S., Han, S. N., & Jang, Y. J. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.11.038 · Cited by 12
Omega-3 Long-Chain Polyunsaturated Fatty Acids in the Elderly: A Review
Gareri, P. (2022) · OBM Geriatrics · doi:10.21926/obm.geriatr.2202198 · Cited by 11
Zeina, A., Kopelman, Y., Mari, A., Ahmad, H. S., Artul, S., Khalaila, A. S., Taher, R., Villannueva, F. Z., Safadi, R., Mouch, S. A., et al. (2022) · Medicine · doi:10.1097/md.0000000000031710 · Cited by 11
Alomari, M., Rashid, M. U., Chadalavada, P. N., Ragheb, J. G., Zafar, H., Suarez, Z. K., Khazaaleh, S., Gonzalez, A. J., & Castro, F. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i4.477 · Cited by 13
Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease
Aggeletopoulou, I., Kalafateli, M., Tsounis, E. P., & Triantos, C. K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612864 · Cited by 11
“Nonalcoholic fatty liver disease (NAFLD) is a common liver condition affecting approximately 25% of the global population (20–30% of the Western population [1,2] and up to 34.”
BackgroundThe Effect of miRNA‐122 in Regulating Fat Deposition in a Cell Line Model
Nie, Y., Cao, J., Zhou, Y., Liang, X., Du, Y., Wan, Y. Y., & Li, Y. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24725 · Cited by 12
“Over‐expression of miR‐122 reduced tumorigenic properties of HCC cell lines [Bai et al., 2009].”
BackgroundLiu, Z., Hu, Y., Yang, X., Tan, A., Gao, Y., Qin, X. Y., Liang, Y., Mo, Z., & Peng, T. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.08.022 · Cited by 11
Krawczyńska, A., Herman, A. P., Antushevich, H., Bochenek, J., Dziendzikowska, K., Gajewska, A., & Gromadzka-Ostrowska, J. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.07.012 · Cited by 12
Does Simple Steatosis Affect Liver Regeneration after Partial Hepatectomy in Rats?
Garnol, T., Kučera, O., Staňková, P., Lotková, H., & Červinková, Z. (2016) · Acta Medica (Hradec Kralove Czech Republic) · doi:10.14712/18059694.2016.87 · Cited by 11
Lycopene and Tomato Sauce Improve Hepatic and Cardiac Cell Biomarkers in Rats
de Jesuz, V. A., Campos, M. D. B. E., de Souza, V. R., Bedê, T. P., de Moraes, B. P. T., Silva, A. R., Gonçalves-de-Albuquerque, C. F., de Azeredo, V. B., & Teodoro, A. J. (2019) · Journal of Medicinal Food · doi:10.1089/jmf.2019.0014 · Cited by 13
“3 The consumption of diets rich in saturated fats is linked to synthesis of proinflammatory cytokines, an increase in reactive oxygen species, development of oxidative stress, and damage to several biomolecules.”
Prahastuti, S., Ladi, J. E., Dewi, K., Albertina, F., & Imam, M. K. (2020) · Journal Of Medicine & Health · doi:10.28932/jmh.v2i5.2040 · Cited by 12
“Dislipidemia berhubungan dengan Non Alcoholic Fatty Liver Disease (NAFLD).1 Kondisi NAFLD merupakan spektrum kelainan hati dengan gambaran khas berupa steatosis (perlemakan) makrovesikular yang muncul pada pasien yang tidak mengonsumsi alkohol dalam jumlah yang dianggap berbahaya bagi hati yaitu 20 gram etanol per min…”
BackgroundLower Rates of Hepatocellular Carcinoma Observed Among Cannabis Users: A Population-Based Study
ElTelbany, A., Khoudari, G., Al‐Khadra, Y., McCullough, A. J., & Alkhouri, N. (2022) · Cureus · doi:10.7759/cureus.24576 · Cited by 12
Tong, Q., Gao, X., Lei, L., Zhang, W., Feng, J., Wang, X., Shen, Z., Liu, Z., Yi, H., Wu, S., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114903 · Cited by 11
Prevalence and related factors of non-alcoholic fatty liver disease among the elderly in Taiwan
Hung, S.-C., Lai, S.-W., Chen, M.-C., Li, P.-C., & Lin, K. (2012) · European Geriatric Medicine · doi:10.1016/j.eurger.2012.11.004 · Cited by 11
Mustonen, A., Kärjä, V. J., Kilpiö, M., Tammi, R., Tammi, M., Rouvinen‐Watt, K., Halonen, T., & Nieminen, P. (2013) · Nutrients · doi:10.3390/nu5104211 · Cited by 12
“NAFLD is closely associated with features of the metabolic syndrome, such as obesity, insulin resistance, hyperlipidemia, and hypertension, but can also occur in starvation [1,2].”
BackgroundLópez‐Amador, N., Nolasco-Hipólito, C., Jimeno, M. D. J. R., & Carvajal‐Zarrabal, O. (2017) · Clinical Investigation · doi:10.4172/clinical-investigation.1000107 · Cited by 11
“[20] Also, it has been shown that NAFLD increases proportionally with BMI; in this study, eight patients with NAFLD were found to have a BMI >40 Kg/m2.”
BackgroundAntipass, A., Austin, A. S., Awad, S., Hughes, D., & IDRIS, I. R. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04486-4 · Cited by 11
Radwan, M. M., Radwan, B. M., Nandipati, K. C., Hunter, W. J., & Agrawal, D. K. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2013.816484 · Cited by 16
Fu, S., Lin, Y. H., Luo, L., & Ye, P. (2017) · BMC Gastroenterology · doi:10.1186/s12876-017-0607-8 · Cited by 10
Sharma, C., & Badyal, A. (2021) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20212085 · Cited by 10
“In Western countries, NAFLD is the most common liver disease with a prevalence of 20-30%.(20) Foster et al in 2013 showed a prevalence of 24% in the United States of America with more prevalence in African Americans.”
BackgroundFatty Liver Is an Independent Risk Factor for Delayed Recovery from Anesthesia
Shapses, M. A., Tang, L., Layne, A., Beri, A., & Rotman, Y. (2021) · Hepatology Communications · doi:10.1002/hep4.1772 · Cited by 10
Karimi, M., Abiri, B., Guest, P. C., & Vafa, M. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1558-4_2 · Cited by 14
Hachuła, M., Kosowski, M., Basiak, M., & Okopień, B. (2023) · Pharmaceuticals · doi:10.3390/ph16091190 · Cited by 10
“Obesity causes insulin resistance and is also a main risk factor for MASLD [4].”
BackgroundGates, L. D., Adler, R. R., & Elangbam, C. S. (2016) · Journal of Histotechnology · doi:10.1080/01478885.2015.1106072 · Cited by 12
Mohamed, A. A., Eldemery, A. B., Abdulgawad, E. A., Moussa, S. M., Halim, A. A., Mostafa, S. M., Abdelghany, R. S., Mahmoud, S., El‐Kady, M. A., Raafat, K., et al. (2021) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00257-5 · Cited by 10
Wei, H., Zhang, T., Yan, J., Yu, J., He, B., Wu, L., Yao, K., Mao, W., & Chen, Z. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211055099 · Cited by 10
Lampignano, L., Donghia, R., Sila, A., Bortone, I., Tatoli, R., Nucci, S. D., Castellana, F., Zupo, R., Tirelli, S., Giannoccaro, V., et al. (2022) · Nutrients · doi:10.3390/nu14020258 · Cited by 10
Zhou, Y. J., Zhang, Z. S., Nie, Y. Q., Cao, J., Cao, C. Y., & Li, Y. Y. (2015) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12288 · Cited by 10
RetractedNon-Alcoholic Fatty Liver Disease: Diagnosis and Investigation
Nascimbeni, F., Loria, P., & Ratziu, V. (2014) · Digestive Diseases · doi:10.1159/000360510 · Cited by 12
Prysyazhnyuk, V. P., Rossokha, Z. I., & Горовенко, Н. Г. (2017) · Cytology and Genetics · doi:10.3103/s0095452717060111 · Cited by 10
Non-alcoholic fatty liver infiltration in children: an underdiagnosed evolving disease
Tzifi, F., Fretzayas, A., Chrousos, G. P., & Kanaka‐Gantenbein, C. (2019) · HORMONES · doi:10.1007/s42000-019-00107-7 · Cited by 11
Chao, H., & Lin, H.-Y. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.724426 · Cited by 11
“Ultrasound (US) of the liver is the most common technique for screening fatty liver in the general population (9); it is a fast, readily available, and relatively reliable method to diagnose fatty liver when Fibroscan is not available.”
BackgroundHidalgo, I., Ortíz-Flores, M., Villarreal, F. J., Fonseca-Coronado, S., Ceballos, G. M., Meaney, E., & Nájera, N. (2022) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2021-0285 · Cited by 10
Lipocalin 2 in the pathogenesis of fatty liver disease and nonalcoholic steatohepatitis
Asimakopoulou, A., & Weiskirchen, R. (2015) · Clinical Lipidology · doi:10.2217/clp.14.65 · Cited by 10
Role of intestinal microbiota in the formation of non-alcoholic fatty liver disease
Ахмедов, В. А., & Gaus, O. V. (2019) · Terapevticheskii arkhiv · doi:10.26442/00403660.2019.02.000051 · Cited by 13
“На протяжении многих лет для описания НАЖБП использовались различные термины, такие как «псевдоалкогольный гепатит», «подобный алкогольному гепатит», «стеатонекроз» и «диабетический гепатит», а совсем недавно появились новые аббревиатуры – BASH (как алкогольное, так и безалкогольное заболевание печени), DASH (стеатоге…”
Zhou, Z., Li, L., Duan, J., Zhu, J., Wang, X., Guo, J., Li, K., Shi, L., Wong, W. T., Cheung, P. C. K., et al. (2025) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2025.124687 · Cited by 9
Siegert, S., Yu, Z., Wang‐Sattler, R., Illig, T., Adamski, J., Hampe, J., Nikolaus, S., Schreiber, S., Krawczak, M., Nothnagel, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076813 · Cited by 10
“Non-alcoholic fatty liver disease (NAFLD), a sub-phenotype that is characterized by fat accumulation in the liver (>5% of the liver weight) in the absence of excessive alcohol intake (<20g per day), represents the most common form of chronic liver disease [1].”
BackgroundMethodInfluentialNiemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease
Christensen, C. U., Glavind, E., Thomsen, K. L., Kim, Y. O., Heebøll, S., Schuppan, D., Hamilton-Dutoit, S. J., Heegaard, C. W., & Grønbæk, H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192728 · Cited by 9
“The prevalence of NAFLD in the general population of Western countries is 20–30%, and NASH affects 3–5% of the general adult population and up to 20–40% of obese and diabetic patients[1,2].”
BackgroundVujanović, M., Brkić-Jovanović, N., Ilic, D., Drvendžija, Z., Srdić, B., Turkulov, V., Brkic, S. V., & Marić, D. (2019) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v20i1.968 · Cited by 9
Zhang, Z., Li, M., Cui, B., & Chen, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.829686 · Cited by 12
“This research has indicated that NAFLD is related to obesity, hyperlipidaemia and gut microbial dysbiosis (Bellentani et al., 2010; Chen et al., 2020b).”
BackgroundMburu, A. N., Laving, A., Macharia, W., & Sande, J. (2023) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2022-001044 · Cited by 9
Aljahdali, B. A., Bajaber, A. S., Al-Nouri, D. M., Alkhalifah, A., Arzoo, S., & Alasmari, A. A. (2023) · Life · doi:10.3390/life13061336 · Cited by 9
“The spread of NAFLD has reached epidemic proportions, impacting about 25% of the world’s population [2,3].”
BackgroundFleming, M. M., Liu, F., Zhang, Y., & Pei, K. Y. (2018) · World Journal of Surgery · doi:10.1007/s00268-018-4591-0 · Cited by 9
Molecular and metabolic mechanisms underlying the obesity-cancer link
O’Flanagan, C. H., Bowers, L. W., Allott, E. H., & Hursting, S. D. (2018) · Research Portal (Queen's University Belfast) · Cited by 10
Guo, W., Wu, D., Dao, M. C., Li, L., Lewis, E. D., Ortega, E. F., Eom, H., Thomas, M., Nikolova‐Karakashian, M., Meydani, M., et al. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa259 · Cited by 10
Grover, V., Duseja, A. K., Chahal, G., Jain, A., Mehta, M., & Ranjan, A. (2020) · Journal of Indian Society of Periodontology · doi:10.4103/jisp.jisp_45_20 · Cited by 10
“[13] The overall prevalence of NAFLD varies from 15% to 40% and 9%–40% in Western countries and in Asian countries, respectively.[14-16] NAFLD is an emerging cause of liver disease in our country as well.”
BackgroundComparative analysis of metabolic risk factors for progression of non-alcoholic fatty liver disease
Yao, V. J. H., Sun, M., Rahman, A. A., Samuel, Z., Chan, J., Zheng, E. X., & Yao, A. (2021) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2021.107567 · Cited by 9
Niacin increases diet-induced hepatic steatosis in B6129 mice
Fang, H., Li, Z., Graff, E. C., MCCAFFERTY, K. J., & Judd, R. L. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158731 · Cited by 12
Mandal, B., Das, R., & Mondal, S. (2024) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2024.02.005 · Cited by 9
Sukkasem, N., Chatuphonprasert, W., & Jarukamjorn, K. (2020) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v19i4.5 · Cited by 10
“The development of NAFLD is associated with excess fat consumption and metabolic syndromes [1].”
Namkhah, Z., Naeini, F., Ostadrahimi, A., Tutunchi, H., & Hosseinzadeh‐Attar, M. J. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.13985 · Cited by 10
Okamura, T., Hashimoto, Y., Hamaguchi, M., Obora, A., Kojima, T., & Fukui, M. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01809-2 · Cited by 10
Senussi, N. H., & McCarthy, D. M. (2021) · Annals of Hepatology · doi:10.1016/j.aohep.2021.100526 · Cited by 8
“In Western countries, the prevalence in the general population is estimated to be up to 30 percent [5].”
BackgroundLiver enzymes: No trivial elevations, even if asymptomatic
Agganis, B. T., Lee, D. J., & Sepe, T. E. (2018) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.85a.17103 · Cited by 10
Prediction of Hepatic Steatosis (Fatty Liver) using Machine Learning
Deo, R., & Panigrahi, S. (2019) · International Conference on Computational Biology and Bioinformatics (ICCBB) · doi:10.1145/3365966.3365968 · Cited by 9
“Prior statistics indicate that NAFLD occurs at higher percentages among obese adults (80 90%) and hyperlipidemia patients (90%) [2].”
BackgroundInfluentialAkbarzadeh, Z., Nourian, M., Askari, G., Maracy, M. R., & Rafiei, R. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 13
Boulouta, A., Aggeletopoulou, I., Kanaloupitis, S., Tsounis, E. P., Issaris, V., Papantoniou, K., Apostolos, A., Tsaplaris, P., Pastras, P., Sotiropoulos, C., et al. (2022) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2022.101896 · Cited by 8
Prakash, K., & Saradha, S. (2022) · International Conference on Edge Computing and Applications (ICECAA) · doi:10.1109/icecaa55415.2022.9936406 · Cited by 8
“These kinds of innovations provide an effective Quality-of-Service (QoS) to the patients and physicians with proper accuracy metrics [2].”
BackgroundChaves, G. V., de Souza, D. S., Pereira, S., Saboya, C. J., & Peres, W. A. F. (2012) · Revista da Associação Médica Brasileira (English Edition) · doi:10.1016/s2255-4823(12)70197-2 · Cited by 8
“292 Rev Assoc Med Bras 2012; 58(3):288-293 intrinsic defect of the disease and the lower response to insulin in adipocytes stimulates tissue lipolysis, contributing to the progressive accumulation of lipids in hepatocytes through an increased flow of free fatty acids in the liver36.”
BackgroundInfluentialTINIAKOS, D. G., Anstee, Q. M., Brunt, E. M., & Burt, A. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00005-3 · Cited by 9
Wu, M., Yuan, C., Lu, L., An, B., Xuan, S., & Xin, Y. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0367-4 · Cited by 7
Alam, S., Anam, K., Islam, S., Mustafa, G., Mamun, A. A., & Ahmad, N. (2018) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2018.06.011 · Cited by 7
Metadata
- Authors
- Bellentani, S., Scaglioni, F., Marino, M., & Bedogni, G.
- Venue
- Digestive Diseases
- Publisher
- S. Karger AG
- Published
- 2010
- Volume
- 28
- Issue
- 1
- Pages
- 155-161
- ISSN
- 0257-2753 (ISSN-L)
- 1421-9875
- OpenAlex
- W2036047239
- Cited by
- 1,026
- References
- 77
- Citations by year
- 2026: 7 · 2025: 19 · 2024: 31 · 2023: 51 · 2022: 72 · 2021: 71 · 2020: 78 · 2019: 85 · 2018: 96 · 2017: 97 · 2016: 89 · 2015: 84 · 2014: 71 · 2013: 81 · 2012: 48
- FWCI
- 40.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Digestive Diseases (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- non-alcoholic fatty liver disease, prevalence, nonalcoholic steatohepatitis, liver cirrhosis, hepatocellular carcinoma, risk factors, obesity, insulin resistance, metabolic syndrome, fatty liver index, NAFLD screening, pediatric NAFLD, incidence, lifestyle, transaminases
- MeSH terms
- Adult, Aged, Fatty Liver, Female, Humans, Italy, Male, Middle Aged, Risk Factors, United States, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.